Table 1

Association analysis of HLA class I genes associated with SJS/TEN with SOC using combined data of patients with SJS/TEN

HLACarrier frequencyGene frequency
Cases (%) (n=71)Controls (%) (n=119)P valuesPc-values*OR (95% CI)Cases (%) (n=142)Controls (%)(n=318)P valuesPc-values*OR (95% CI)
A*33:0343.7(31/71)23.3(37/159)0.0028†0.0333†2.56(1.41 to 4.64)24.6(35/142)11.9(38/318)0.0009†0.0104†2.41(1.45 to 4.02)
B*27:040(0/71)9.4(15/159)0.0066†0.12000.0652 (0.003 to 1.11)0(0/142)4.7(15/318)0.0076†0.13600.0687 (0.004 to 1.16)
B*44:0331(22/71)6.9(11/159)<0.0001†0.0001†6.04(2.73 to 13.3)16.9(24/142)3.5(11/318)<0.0001†<0.0001†5.68(2.70 to 12.0)
C*07:0133.8(24/71)9.4(15/159)<0.0001†0.0002†4.90(2.38 to 10.10)19(27/142)4.7(15/318)<0.0001†<0.0001†4.74(2.43 to 9.24)
C*12:021.4(1/71)11.9(19/159)0.0093†0.14000.105(0.01 to 0.80)0.7(1/142)6(19/318)0.0110†0.16500.112(0.01 to 0.84)
  • *The corrected p value indicates the p value after multiple comparisons (12 for HLA-A, 18 for HLA-B and 15 for HLA-C).

  • †Analysis showed significant association between HLA and SJS/TEN with SOC at p<0.05.

  • HLA, human leucocyte antigen; SJS/TEN, Stevens-Johnson syndrome/toxic epidermal necrolysis; SOC, severe ocular complications.